v0.13 🌳  

Kent Lake Capital LLC Adjusts Stock Positions in CareDx, Inc and TransMedics Group, Inc

2024-04-07 00:24:02.528000

Kent Lake Capital LLC, an investment firm, has made adjustments to its stock positions in two healthcare companies. According to a recent filing with the SEC, Kent Lake Capital LLC reduced its stake in CareDx, Inc (NASDAQ:CDNA) by 55.0% during the 4th quarter. They sold 757,157 shares, leaving them with 618,301 shares of the company's stock. CareDx now represents 2.9% of Kent Lake Capital LLC's investment portfolio, making it their 15th largest holding. The value of their stake in CareDx is approximately $7.42 million. [c02b9c28]

In addition to CareDx, Kent Lake Capital LLC also reduced its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX) by 45.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 55,000 shares of TransMedics Group's stock after selling 45,000 shares during the quarter. TransMedics Group accounts for about 1.7% of Kent Lake Capital LLC's holdings, making it the stock their 25th biggest position. The value of their stake in TransMedics Group is approximately $4.34 million. [e5a11337]

Other institutional investors and hedge funds have also made adjustments to their positions in these companies. US Bancorp DE increased their holdings in CareDx by 95.8% in the 4th quarter, while Headlands Technologies LLC acquired a new position in the company. Royal Bank of Canada also increased their position in CareDx by 127.6% in the 2nd quarter. WINTON GROUP Ltd purchased shares in CareDx in the 3rd quarter, and Nisa Investment Advisors LLC increased their position in the 4th quarter. Envestnet Asset Management Inc. raised its position in TransMedics Group by 19.6% in the fourth quarter. Public Employees Retirement Association of Colorado raised its position in TransMedics Group by 289.4% in the fourth quarter. Oppenheimer & Co. Inc. raised its position in TransMedics Group by 15.2% in the fourth quarter. Tower Research Capital LLC TRC raised its position in TransMedics Group by 89.3% in the fourth quarter. Goldman Sachs Group Inc. raised its position in TransMedics Group by 10.9% in the fourth quarter. [c02b9c28] [e5a11337]

CareDx, Inc is a healthcare company that provides solutions and services to healthcare organizations. The company's stock has a 52-week low of $4.80 and a 52-week high of $12.93. It has a market capitalization of $498.64 million and a P/E ratio of -2.72. CareDx last reported quarterly earnings on February 28th, with a net margin of -67.88% and a negative return on equity of 51.40%. The company's revenue for the quarter was $65.57 million, down 20.4% from the previous year. Analysts expect CareDx to post earnings per share of -1.59 for the current year. [c02b9c28]

TransMedics Group, Inc. is a healthcare company that specializes in organ transplant solutions. The company's stock is held by various institutional investors and hedge funds. [e5a11337]

Disclaimer: The story curated or synthesized by the AI agents may not always be accurate or complete. It is provided for informational purposes only and should not be relied upon as legal, financial, or professional advice. Please use your own discretion.